XLS
Xlife Sciences Stock
StockStockISIN: CH0461929603
Ticker: XLS
CH0461929603
XLS
Price
Frequently asked questions
What is Xlife Sciences's market capitalization?
The market capitalization of Xlife Sciences is $174.51M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Xlife Sciences's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Xlife Sciences is 11.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Xlife Sciences?
Xlife Sciences's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.702. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Xlife Sciences's stock?
Currently, 1 analysts cover Xlife Sciences's stock, with a consensus target price of . Analyst ratings provide insights into the stock's expected performance.
What is Xlife Sciences's revenue over the trailing twelve months?
Over the trailing twelve months, Xlife Sciences reported a revenue of $1.12M.
What is the EBITDA for Xlife Sciences?
Xlife Sciences's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$2.99M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Xlife Sciences?
Xlife Sciences has a free cash flow of $2.17M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Xlife Sciences have, and what sector and industry does it belong to?
Xlife Sciences employs approximately 17 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.
What is the free float of Xlife Sciences's shares?
The free float of Xlife Sciences is 2.89M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$174.51MEPS (TTM)
$2.702Free Float
2.89MP/E ratio (TTM)
11.25Revenue (TTM)
$1.12MEBITDA (TTM)
-$2.99MFree Cashflow (TTM)
$2.17MPricing
52W span
$26.82$48.07
Analyst Ratings
The price target is and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.
17
Biotechnology & Drugs
Health Care
Identifier
ISIN
CH0461929603
Primary Ticker
XLS